Developer docs
API playgroundTry for free, no card

Search company profiles

PharmaCord

Full company profile

uuid00068ar

Namestring
PharmaCord
Legal namestring
PharmaCord
Websiteurl
pharmacord.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

PharmaCord is a privately held US healthcare services company headquartered in Jeffersonville, Indiana, founded in 2016. The company delivers specialty pharmaceutical patient support services and hub services to pharmaceutical manufacturers, addressing patient access, affordability, adherence, and engagement requirements for specialty medications. Its technology-enabled platform coordinates end-to-end commercialization workflows and currently supports over 100 pharmaceutical products across the United States.

The company's customer base is concentrated in the pharmaceutical manufacturing vertical, where it functions as a service-provider partner helping manufacturers reach and support patients on complex specialty therapies. PharmaCord's operating model is structured around long-term service contracts with manufacturers, though specific pricing models and revenue mechanics are not publicly disclosed. Its core technology stack centers on a proprietary specialty pharmaceutical patient services and hub services platform, with stated expansion capabilities intended to broaden the technology footprint. In June 2024, PharmaCord received a substantial investment from Permira, a global private equity firm, to fund growth, expand its technological offerings, and accelerate its position in the specialty pharma services sector. The company employs between 1,001 and 5,000 people and currently operates a US-only footprint.

Short descriptiontext

PharmaCord is a US-based specialty pharmaceutical patient services and hub services provider that partners with pharmaceutical manufacturers to deliver technology-enabled access, affordability, adherence, and engagement support across over 100 specialty therapy products.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersJeffersonville, United States
HQ citystring
Jeffersonville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
specialty pharmaceutical services, patient hub services, patient access solutions, pharma patient support, medication adherence programs
Industry2 codes
PRIMARYHLAIAKAG
Patient Access Programs & Affordability (Copay/Hubs/PSP)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
NAICS code1 code
  • Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds524292
SIC code1 code
  • Services-Health Services8000
Product category
Specialty Pharmaceutical Patient Services
Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

PharmaCord is a healthcare services company that provides specialty pharmaceutical hub services supporting over 100 pharmaceutical products. The company delivers patient access, affordability, adherence, and engagement solutions that help pharmaceutical manufacturers connect patients prescribed specialty medications with the therapies, financial assistance, and ongoing support they need.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

PharmaCord is a pharma services company offering patient support services for the pharmaceutical industry, with a focus on specialty medications. The company supports over 100 pharmaceutical products through hub services that improve patient experience. Based in Jeffersonville, Indiana, PharmaCord provides end-to-end commercialization services including patient access, affordability programs, and specialty pharmacy coordination.

Product and service3 records
1Specialty Pharmaceutical Hub Services
CategoryPatient Support Services
Description

End-to-end hub services that help pharmaceutical manufacturers deliver, coordinate, and support specialty medications for patients, covering access, affordability, adherence, and engagement.

2Patient Access and Affordability Programs
CategoryPatient Support Services
Description

Services that help patients prescribed specialty medications gain access to therapies through benefits investigation, prior authorization support, copay assistance, and financial aid program coordination.

3Patient Adherence and Engagement Solutions
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

ConnectiveRx delivers patient access, affordability, and adherence solutions combined with pharmacy network services, competing with PharmaCord for specialty pharmaceutical manufacturer contracts.

TypeDirect peer
Description

CareMetx delivers hub services, patient support, and specialty pharmacy coordination for specialty drug manufacturers, directly competing with PharmaCord for manufacturer contracts across access and adherence programs.

TypeDirect peer
Description

EVERSANA is an integrated commercial services provider offering patient access, hub services, adherence, and affordability solutions for life sciences manufacturers—overlapping substantially with PharmaCord's end-to-end commercialization offering.

4Triplefin
TypeDirect peer
Description

Triplefin provides hub services, patient assistance programs, copay support, and pharmacy network solutions for pharma and consumer health manufacturers—a direct competitor to PharmaCord.

TypeBroad incumbent
Description

Syneos Health provides commercial and patient engagement solutions to biopharma, including patient services, market access, and consulting capabilities that intersect with PharmaCord's access and adherence offerings.

TypeDirect peer
Description

Lash Group is a leading patient access and hub services provider serving specialty pharmaceutical manufacturers with reimbursement, copay, adherence, and case management support—the most direct competitor to PharmaCord's core offering.

7McKesson (US Bioservices / Biologics by McKesson)
TypeBroad incumbent
Description

McKesson operates specialty pharmacies and patient services offerings through US Bioservices that compete with PharmaCord's hub services and specialty pharmacy coordination capabilities, leveraging its broader distribution scale.

TypeBroad incumbent
Description

Cardinal Health is a major specialty pharma distributor with patient services and hub offerings that overlap with PharmaCord's services for pharmaceutical manufacturers.

9Sonexus Health
TypeDirect peer
Description

Sonexus Health provides patient access, affordability, and adherence services for specialty medications on behalf of pharma manufacturers, mirroring PharmaCord's hub services model and serving the same client base.

TypeDirect peer
Description

Ashfield Engage, part of Inizio, delivers patient engagement, nurse support, and access services for pharma manufacturers, competing directly with PharmaCord's patient services and adherence offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PharmaCord

Specialty Pharmaceutical Patient Servicespharmacord.com

PharmaCord is a US-based specialty pharmaceutical patient services and hub services provider that partners with pharmaceutical manufacturers to deliver technology-enabled access, affordability, adherence, and engagement support across over 100 specialty therapy products.

What PharmaCord does

PharmaCord is a privately held US healthcare services company headquartered in Jeffersonville, Indiana, founded in 2016. The company delivers specialty pharmaceutical patient support services and hub services to pharmaceutical manufacturers, addressing patient access, affordability, adherence, and engagement requirements for specialty medications. Its technology-enabled platform coordinates end-to-end commercialization workflows and currently supports over 100 pharmaceutical products across the United States.

The company's customer base is concentrated in the pharmaceutical manufacturing vertical, where it functions as a service-provider partner helping manufacturers reach and support patients on complex specialty therapies. PharmaCord's operating model is structured around long-term service contracts with manufacturers, though specific pricing models and revenue mechanics are not publicly disclosed. Its core technology stack centers on a proprietary specialty pharmaceutical patient services and hub services platform, with stated expansion capabilities intended to broaden the technology footprint. In June 2024, PharmaCord received a substantial investment from Permira, a global private equity firm, to fund growth, expand its technological offerings, and accelerate its position in the specialty pharma services sector. The company employs between 1,001 and 5,000 people and currently operates a US-only footprint.

PharmaCord firmographics

Firmographics
Name
PharmaCord
Legal name
PharmaCord
Website
https://pharmacord.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
251–500 employees
Short description
PharmaCord is a US-based specialty pharmaceutical patient services and hub services provider that partners with pharmaceutical manufacturers to deliver technology-enabled access, affordability, adherence, and engagement support across over 100 specialty therapy products.
Ownership category
akta.pro rank

PharmaCord industry classification

Industry
Product category
Specialty Pharmaceutical Patient Services
NAICS
Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAIAKAG
Patient Access Programs & Affordability (Copay/Hubs/PSP)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

Keywords

  • Specialty pharmaceutical services
  • Patient hub services
  • Patient access solutions
  • Pharma patient support
  • Medication adherence programs

Where PharmaCord is headquartered

Location

Headquarters

HQ city
Jeffersonville
HQ country
United States
HQ region
North America

Markets served

PharmaCord business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

PharmaCord product offering

Product offering

Core offering

PharmaCord is a healthcare services company that provides specialty pharmaceutical hub services supporting over 100 pharmaceutical products. The company delivers patient access, affordability, adherence, and engagement solutions that help pharmaceutical manufacturers connect patients prescribed specialty medications with the therapies, financial assistance, and ongoing support they need.

Product overview

PharmaCord is a pharma services company offering patient support services for the pharmaceutical industry, with a focus on specialty medications. The company supports over 100 pharmaceutical products through hub services that improve patient experience. Based in Jeffersonville, Indiana, PharmaCord provides end-to-end commercialization services including patient access, affordability programs, and specialty pharmacy coordination.

Differentiator

Problem solved

Functional benefit

Products and services

  • Specialty Pharmaceutical Hub Services End-to-end hub services that help pharmaceutical manufacturers deliver, coordinate, and support specialty medications for patients, covering access, affordability, adherence, and engagement.
  • Patient Access and Affordability Programs Services that help patients prescribed specialty medications gain access to therapies through benefits investigation, prior authorization support, copay assistance, and financial aid program coordination.
  • Patient Adherence and Engagement Solutions

Companies that use PharmaCord

Customer profile

Segments1 record

Ideal customer profiles1 record

PharmaCord technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

PharmaCord partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves3 records

Expansion highlights5 records

PharmaCord competitors and assessment

Company assessment

Direct peers

  • ConnectiveRx: ConnectiveRx delivers patient access, affordability, and adherence solutions combined with pharmacy network services, competing with PharmaCord for specialty pharmaceutical manufacturer contracts.
  • CareMetx: CareMetx delivers hub services, patient support, and specialty pharmacy coordination for specialty drug manufacturers, directly competing with PharmaCord for manufacturer contracts across access and adherence programs.
  • EVERSANA: EVERSANA is an integrated commercial services provider offering patient access, hub services, adherence, and affordability solutions for life sciences manufacturers—overlapping substantially with PharmaCord's end-to-end commercialization offering.
  • Triplefin: Triplefin provides hub services, patient assistance programs, copay support, and pharmacy network solutions for pharma and consumer health manufacturers—a direct competitor to PharmaCord.
  • Lash Group (AmerisourceBergen/Cencora): Lash Group is a leading patient access and hub services provider serving specialty pharmaceutical manufacturers with reimbursement, copay, adherence, and case management support—the most direct competitor to PharmaCord's core offering.
  • Sonexus Health: Sonexus Health provides patient access, affordability, and adherence services for specialty medications on behalf of pharma manufacturers, mirroring PharmaCord's hub services model and serving the same client base.
  • Ashfield Engage (Inizio): Ashfield Engage, part of Inizio, delivers patient engagement, nurse support, and access services for pharma manufacturers, competing directly with PharmaCord's patient services and adherence offerings.

Broad incumbents

  • Syneos Health: Syneos Health provides commercial and patient engagement solutions to biopharma, including patient services, market access, and consulting capabilities that intersect with PharmaCord's access and adherence offerings.
  • McKesson (US Bioservices / Biologics by McKesson): McKesson operates specialty pharmacies and patient services offerings through US Bioservices that compete with PharmaCord's hub services and specialty pharmacy coordination capabilities, leveraging its broader distribution scale.
  • Cardinal Health (Sonexus / Specialty Networks): Cardinal Health is a major specialty pharma distributor with patient services and hub offerings that overlap with PharmaCord's services for pharmaceutical manufacturers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

PharmaCord social profiles

Digital presence

PharmaCord financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PharmaCord leadership team

Management profile

Number of profiles

Profiles9 records

PharmaCord funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PharmaCord M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmaCord

What does PharmaCord do?

PharmaCord is a healthcare services company that provides specialty pharmaceutical hub services supporting over 100 pharmaceutical products. The company delivers patient access, affordability, adherence, and engagement solutions that help pharmaceutical manufacturers connect patients prescribed specialty medications with the therapies, financial assistance, and ongoing support they need.

Is PharmaCord a public or private company?

PharmaCord is a private company. It is classified as private equity controlled and is currently operating.

When was PharmaCord founded?

PharmaCord was founded in 2016. It employs 251 to 500 people.

Where is PharmaCord based?

PharmaCord is headquartered in Jeffersonville, United States, in the North America region.

Who are PharmaCord's main competitors?

Direct peers on record are ConnectiveRx, CareMetx, EVERSANA, Triplefin, Lash Group (AmerisourceBergen/Cencora), Sonexus Health and Ashfield Engage (Inizio). Broad incumbents are Syneos Health, McKesson (US Bioservices / Biologics by McKesson) and Cardinal Health (Sonexus / Specialty Networks).

Does PharmaCord have an API?

No public API is recorded for PharmaCord.

What industry is PharmaCord in?

PharmaCord's product category is Specialty Pharmaceutical Patient Services. Its primary akta.pro industry code is HLAIAKAG, Patient Access Programs & Affordability (Copay/Hubs/PSP), with a secondary code of HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 524292 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PharmaCommerceThe Hub Services Wheel keeps Rolling AlongThe article examines the growth and increasing competition in hub services and patient support providers serving the specialty pharmaceutical industry, noting continued private equity investment and business realignments in 2017. Key transactions include the sale of Dohmen Life Sciences Services to Water Street Healthcare Partners and JLL Partners, and McKesson's acquisition of RxCrossroads from CVS Health. The piece profiles multiple industry participants including TrialCard, Triplefin, PharmaCord, and CoverMyMeds, discussing their service models, technology platforms, and positioning within the evolving hub services ecosystem.YahooPharmaCord and Mercalis to Merge, Creating Next-Generation Platform to Meet Evolving Needs of the Biopharmaceutical IndustryPharmaCord and Mercalis announced a merger to create a next-generation patient access platform for the biopharmaceutical industry. The combined company will be majority owned by Permira funds, with Robert Truckenmiller as CEO and Scott Dulitz as President. The transaction is expected to close by the third quarter of 2025.Business Wire BlogPharmaCord and Mercalis to Merge, Creating Next-Generation Platform to Meet Evolving Needs of the Biopharmaceutical IndustryPharmaCord and Mercalis announced a merger to create a next-generation patient access platform for the biopharmaceutical industry. The combined company will be majority owned by Permira funds, with Robert Truckenmiller as CEO and Scott Dulitz as President. The transaction is expected to close by the third quarter of 2025.Pulse 2.0Permira: Substantial Investment In PharmaCord RevealedA company backed by Permira funds signed a definitive agreement to make a substantial investment in PharmaCord, a pharma patient services provider. The terms were undisclosed, and the deal is expected to close by the fourth quarter of 2024. PharmaCord serves over 100 pharmaceutical products with 30+ clients.FinSMEsPharmaCord Receives Investment from PermiraPharmaCord, a pharma services company based in Jeffersonville, Indiana, has secured an investment from private equity firm Permira. The undisclosed deal is expected to close by the fourth quarter of 2024 following customary regulatory approvals. PharmaCord intends to utilize these funds to expand its operations and business reach.LinkedInPermira Announces Substantial Investment in PharmaCordPrivate equity firm Permira announced a substantial investment in PharmaCord, a US-based pharmaceutical services company. The capital is intended to support PharmaCord's expansion initiatives and its mission to enhance the patient experience for specialty medications through improved access and therapy adherence.PermiraPermira Announces Substantial Investment in PharmaCordPermira announced a substantial investment in PharmaCord, with the company's founder and management team remaining as significant investors to continue leading operations. The transaction, which is expected to close by the fourth quarter of 2024, aims to support PharmaCord's expansion efforts and enhance its tech-enabled patient services for specialty medications.Business Wire BlogPermira Announces Substantial Investment in PharmaCordPermira-backed funds signed a definitive agreement to make a substantial investment in PharmaCord, a patient services provider for pharmaceuticals. Terms were not disclosed, and the deal is expected to close by the fourth quarter of 2024. PharmaCord's CEO Nitin Sahney said the partnership will support expansion efforts.NewswirePharmaCord to Add More Than 500 New Jobs as It Prepares for Its Next Phase of GrowthPharmaCord announced plans to hire more than 500 employees from the region to support new client program implementations. The company, which grew from 20 to over 500 employees in five years, expects to exit 2023 with over 1,000 employees. It will hire roles including benefit specialists, case managers, and software developers.NewswirePharmaCord Appoints Beth Roberts to Vice President, AdministrationPharmaCord promoted Beth Roberts to Vice President of Administration, effective January 18, 2022. She will oversee facility management and support business development, continuing as an executive committee member. Roberts previously served as Senior Director of Administration.